Stifel Financial Corp Embecta Corp. Transaction History

Stifel Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2023 May 12, 2023	SELL	$23.07 - $32.77 $246,618 - $350,311	-10,690 Reduced 55.36%	8,620 $242,000
Q4 2022 Feb 13, 2023	SELL	$25.29 - $35.48 $240,280 - $337,095	-9,501 Reduced 32.98%	19,310 $488,000
Q3 2022 Nov 14, 2022	SELL	$24.0 - $33.42 $3.96 Million - $5.52 Million	-165,055 Reduced 85.14%	28,811 $829,000
Q2 2022 Aug 15, 2022	BUY	$24.78 - $33.36 $4.8 Million - $6.47 Million	193,866 New	193,866 $4.91 Million

406

52.4M

120K

66.8K

Ticker EMBC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 57,836,500
Market Cap $745M
Description
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...

Get notified when there are updates to the investment portfolio of Stifel Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Stifel Financial Corp with notifications on news.